MAPT and Alzheimer disease: Collectively, these data suggest that pathogenic tau drives the elevation of Moesin detected in human Alzheimer’s disease and that aberrant Moesin activation mediates actin over-stabilization, cell cycle activation, and consequent neuronal death in tauopathy.